10.20
전일 마감가:
$10.15
열려 있는:
$10.15
하루 거래량:
4.46M
Relative Volume:
0.94
시가총액:
$2.04B
수익:
$3.68B
순이익/손실:
$-627.00M
주가수익비율:
-3.2405
EPS:
-3.1477
순현금흐름:
$104.00M
1주 성능:
-2.39%
1개월 성능:
-0.10%
6개월 성능:
-7.94%
1년 성능:
-34.11%
덴츠플라이 Stock (XRAY) Company Profile
명칭
Dentsply Sirona Inc
전화
844-546-3722
주소
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
XRAY
Dentsply Sirona Inc
|
10.20 | 2.04B | 3.68B | -627.00M | 104.00M | -3.1477 |
|
ISRG
Intuitive Surgical Inc
|
403.18 | 142.79B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
143.92 | 39.66B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
66.12 | 32.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
35.30 | 29.85B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
191.26 | 27.74B | 5.54B | 1.52B | 1.74B | 10.37 |
덴츠플라이 Stock (XRAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Sell |
| 2026-02-19 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-01-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | 재확인 | Needham | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-11-16 | 개시 | Needham | Buy |
| 2023-11-10 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | 업그레이드 | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-04-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | 개시 | Morgan Stanley | Overweight |
| 2021-10-01 | 재개 | Credit Suisse | Outperform |
| 2021-08-09 | 재확인 | H.C. Wainwright | Neutral |
| 2021-08-06 | 재확인 | Barrington Research | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-03-02 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | 재확인 | H.C. Wainwright | Neutral |
| 2021-01-05 | 재확인 | H.C. Wainwright | Neutral |
| 2020-12-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-11-17 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-11-09 | 재확인 | H.C. Wainwright | Neutral |
| 2020-10-22 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-08-10 | 재확인 | H.C. Wainwright | Neutral |
| 2020-06-16 | 개시 | Piper Sandler | Overweight |
| 2020-06-15 | 재확인 | H.C. Wainwright | Neutral |
| 2020-05-27 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-05-11 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | 재확인 | H.C. Wainwright | Neutral |
| 2020-04-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-19 | 재확인 | Stifel | Buy |
| 2019-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-08-02 | 업그레이드 | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | 개시 | Evercore ISI | In-line |
| 2019-07-09 | 재확인 | H.C. Wainwright | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
모두보기
덴츠플라이 주식(XRAY)의 최신 뉴스
Dental Equipment & Technology Stocks Q1 In Review: Dentsply Sirona (NASDAQ:XRAY) Vs Peers - TradingView
DENTSPLY SIRONA (XRAY) Stock Could Be 78% Undervalued After CFO Appointment - Sahm
Thursday insider buys and sells: Directors load up on healthcare By Investing.com - Investing.com Nigeria
Dentsply Sirona director Jonathan Mazelsky buys $101,400 in shares - Investing.com UK
XRAY News | DENTSPLY SIRONA INC (NASDAQ:XRAY) - ChartMill
Dentsply Sirona director Jonathan Mazelsky buys $101,400 in shares By Investing.com - Investing.com Canada
Dentsply Sirona (XRAY) director amends Form 4 to show share purchase - Stock Titan
Dentsply Sirona (XRAY) SVP details stock, RSU, phantom and option holdings - Stock Titan
DENTSPLY SIRONA Inc (XRAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mitsui Chemicals to acquire Ultradent - DrBicuspid.com
DENTSPLY SIRONA (XRAY) 10K Form and Latest SEC Filings 2026 - MarketBeat
DENTSPLY SIRONA Inc (XRAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DENTSPLY SIRONA Inc (XRAY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DENTSPLY SIRONA Inc (XRAY) Institutional Confidence - TradingKey
DENTSPLY SIRONA Inc (XRAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DENTSPLY SIRONA Inc (XRAY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Dentsply Sirona director Clyde Hosein buys $64,902 in common stock By Investing.com - Investing.com India
Dentsply Sirona director Clyde Hosein buys $64,902 in common stock - Investing.com
Insider Buying: Clyde Hosein Acquires Shares of Dentsply Sirona Inc (XRAY) - GuruFocus
Is It Too Late to Buy Dentsply Sirona Inc (XRAY) After 3.2% Rall - GuruFocus
Director Clyde Hosein buys 6,500 DENTSPLY SIRONA (XRAY) shares at $9.985 - Stock Titan
Dentsply Sirona director Brian Gladden buys $100k in stock By Investing.com - Investing.com India
Dentsply Sirona director Brian Gladden buys $100k in stock - Investing.com
Betsy Holden Acquires Additional Shares of Dentsply Sirona Inc (XRAY) - GuruFocus
Dentsply Sirona director Betsy Holden buys $99,692 in stock By Investing.com - Investing.com Nigeria
Dentsply Sirona director Betsy Holden buys $99,692 in stock - Investing.com UK
Dentsply Sirona director McKeon buys $101,199 in company stock - Investing.com
Director Brian P. McKeon adds 10,000 DENTSPLY SIRONA (XRAY) shares via trust purchase - Stock Titan
DENTSPLY SIRONA (XRAY) director Brian Gladden buys 9,985.022 shares at $10.015 - Stock Titan
Director at DENTSPLY SIRONA (XRAY) receives 10,000-share stock award - Stock Titan
Director Betsy Holden buys 10,086 DENTSPLY SIRONA (XRAY) shares in open market - Stock Titan
DENTSPLY SIRONA (XRAY) director Michael Barber buys 15,175 shares in open market - Stock Titan
Dentsply Sirona names John Fortson as new finance chief - Dental Tribune US
How DENTSPLY SIRONA’s New Veteran CFO Could Shape Capital Allocation and Strategy for XRAY Investors - Yahoo Finance
Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM) - The Globe and Mail
Dentsply Sirona Appoints John Fortson as New CFO - The Globe and Mail
Dentsply Sirona appoints new CFO - CFO Dive
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now - TradingView
Dentsply Sirona (XRAY) Appoints John Fortson as CFO - GuruFocus
Dentsply Sirona appoints John Fortson as CFO - MSN
Dentsply Sirona names John Fortson as CFO effective July 20 - Investing.com UK
Dentsply Sirona Appoints John Fortson as Chief Financial Officer - BioSpace
Dentsply Sirona Inc. Announces Appointment of John C. Fortson as Executive Vice President, Effective July 20, 2026 - marketscreener.com
Dentsply Sirona Inc. Announces Appointment of John C. Fortson as Chief Financial Officer, Effective July 20, 2026 - marketscreener.com
Dentsply Sirona names John Fortson as CFO effective July 20 By Investing.com - Investing.com South Africa
Veteran finance leader John Fortson named CFO at Dentsply Sirona (NASDAQ: XRAY) - Stock Titan
Press Release: Dentsply Sirona Appoints John Fortson as Chief Financial Officer - Moomoo
20%+ Collective Loss | XRAY Stock | Dentsply Sirona Inc Securities Class Action #XRAY Llamas Ruiz (JO8mC5xvnQ) - Mshale
Major dental manufacturers report resilient first quarter - Dental Tribune US
Should DENTSPLY SIRONA’s (XRAY) Nashville Digital Push Redefine Its U.S. Distribution Strategy? - Sahm
Dentsply Sirona stock held at Hold by Needham on execution risk - Investing.com
덴츠플라이 (XRAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):